Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases

Massimo Petruzzi1,2, Sara Galleggiante1, Sabrina Messina1

  • 1Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", Bari, Italy.

BMC Oral Health
|March 25, 2022
PubMed

Insights

Four patients experienced oral erythema multiforme flares after receiving the BNT162b2 COVID-19 vaccine. This rare side effect, potentially linked to the vaccine or reactivated herpes virus, was treated with corticosteroids.

Area of Science:

  • Dermatology
  • Immunology
  • Vaccinology

Background:

  • The COVID-19 pandemic necessitates widespread vaccination, with BNT162b2 being a key vaccine.
  • Adverse events following vaccination are documented, including various cutaneous reactions.
  • Erythema multiforme is a recognized mucocutaneous reaction pattern.

Observation:

  • Four cases of oral erythema multiforme flares post-BNT162b2 vaccination are presented.
  • Patients had no prior history of similar lesions or herpes infections.
  • Lesions appeared after the first or second vaccine dose, with some cases showing both oral and cutaneous involvement.

Findings:

  • The BNT162b2 vaccine may trigger erythema multiforme flares.
  • The exact causal link is unproven, but medication-induced erythema multiforme is known.
  • Reactivation of latent herpes virus infection by the vaccine is a potential mechanism.

Implications:

  • Highlights a rare potential adverse effect of the BNT162b2 COVID-19 vaccine.
  • Suggests vigilance for mucocutaneous reactions post-vaccination.
  • Warrants further investigation into vaccine-associated erythema multiforme and herpes virus reactivation.
Abstract

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
31.6K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
35
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
Allergic Reactions02:06

Allergic Reactions

Overview
29.0K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K